ストックスクリーナーアプリを入手
0.391
5.10%
-0.021
アフターアワーズ：
.39
-0.001
-0.26%
前日終値:
$0.412
開ける：
$0.4316
24時間の取引高:
526.38K
Relative Volume:
1.02
時価総額：
$42.07M
収益：
$1.29M
当期純損益:
$-29.87M
株価収益率:
-1.0861
EPS:
-0.36
ネットキャッシュフロー:
$-14.70M
1週間 パフォーマンス:
-9.91%
1か月 パフォーマンス:
-39.85%
6か月 パフォーマンス:
-24.74%
1年 パフォーマンス:
-40.57%
1日の値動き範囲:
$0.39
$0.4316
1週間の範囲:
$0.39
$0.475
52週間の値動き範囲:
$0.39
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
名前
VolitionRX Ltd
セクター
電話
646 650 1351
住所
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
VNRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.391 | 49.09M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
572.41 | 212.64B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
209.94 | 148.81B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
708.45 | 56.99B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.74 | 41.81B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.46 | 35.91B | 15.90B | 1.28B | 2.21B | 7.2842 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-08 | 開始されました | H.C. Wainwright | Buy |
| 2023-02-01 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-02-17 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-03-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-05-16 | 開始されました | Maxim Group | Buy |
| 2018-05-14 | 繰り返されました | The Benchmark Company | Buy |
| 2016-09-07 | 繰り返されました | Rodman & Renshaw | Buy |
| 2016-02-01 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
VolitionRX Ltd (VNRX) 最新ニュース
Will breakout in VolitionRx Limited lead to full recoveryNew Guidance & Intraday High Probability Alerts - newser.com
VolitionRX (VNRX) to Release Quarterly Earnings on Thursday - Defense World
How VolitionRX Limited stock performs in volatility spikesQuarterly Profit Summary & Consistent Growth Equity Picks - newser.com
Market reaction to VolitionRx Limited’s recent newsMarket Risk Report & Reliable Trade Execution Plans - newser.com
Regression analysis insights on VolitionRx Limited performanceWeekly Profit Analysis & Reliable Entry Point Trade Alerts - newser.com
Can VolitionRx Limited stock maintain operating marginsPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
Is VolitionRx Limited reversing from oversold territory2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Why VolitionRx Limited stock is considered a top pickJuly 2025 Price Swings & High Return Trade Guides - newser.com
Is VolitionRX Limited stock resilient in recession scenarios2025 Sector Review & Safe Entry Point Alerts - newser.com
Is VolitionRx Limited forming a bottoming baseJobs Report & Weekly High Potential Stock Alerts - newser.com
Intraday pattern recognizer results for VolitionRx Limited2025 Technical Patterns & High Yield Stock Recommendations - newser.com
Aug Shorts: How VolitionRx Limited stock benefits from strong dollarJuly 2025 Gainers & Stock Timing and Entry Methods - fcp.pa.gov.br
Using R and stats models for VolitionRx Limited forecastingJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Is VolitionRx Limited stock ready for a breakoutJuly 2025 Update & Consistent Profit Alerts - newser.com
How to use Fibonacci retracement on VolitionRx LimitedJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
Why VolitionRX Limited stock could be next leader2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
Can VolitionRX Limited stock sustain breakout momentumPortfolio Risk Report & Growth Focused Stock Pick Reports - newser.com
VNRX SEC FilingsVolitionrx 10-K, 10-Q, 8-K Forms - Stock Titan
Why analysts remain bullish on VolitionRx Limited stockBear Alert & Weekly High Conviction Trade Ideas - Trung tâm Dự báo KTTV quốc gia
Nu.Q Vet Cancer Tests Donated: Volition Supports HOPE AACR Crisis Dogs at Conference - Stock Titan
Volitionrx director Innes buys $49k in shares By Investing.com - Investing.com Australia
Volitionrx (VNRX) president Reynolds buys $56,100 in shares By Investing.com - Investing.com South Africa
Still buys VolitionRx (VNRX) shares and warrants for $24,518 By Investing.com - Investing.com Canada
VolitionRX Ltd (VNRX) 財務データ
収益
当期純利益
現金流量
EPS
VolitionRX Ltd (VNRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Innes Guy Archibald | Director |
Oct 14 '25 |
Buy |
0.51 |
96,153 |
49,038 |
1,062,967 |
| STILL TIMOTHY I | Director |
Oct 14 '25 |
Buy |
0.51 |
48,076 |
24,519 |
1,535,458 |
| Reynolds Cameron John | President and CEO |
Sep 12 '25 |
Buy |
0.66 |
15,000 |
9,885 |
2,624,847 |
| Innes Guy Archibald | Director |
Aug 05 '25 |
Buy |
0.64 |
78,125 |
50,000 |
966,814 |
| Reynolds Cameron John | President and CEO |
Aug 05 '25 |
Buy |
0.64 |
78,125 |
50,000 |
2,609,847 |
| Reynolds Cameron John | President and CEO |
Jun 12 '25 |
Buy |
0.59 |
12,500 |
7,372 |
2,331,722 |
| Innes Guy Archibald | Director |
Jun 03 '25 |
Buy |
0.54 |
20,000 |
10,772 |
888,689 |
| Micallef Jacob Vincent | Chief Scientific Officer |
May 19 '25 |
Buy |
0.43 |
50,000 |
21,500 |
426,033 |
| Reynolds Cameron John | President and CEO |
May 19 '25 |
Buy |
0.44 |
20,000 |
8,730 |
2,319,222 |
| Reynolds Cameron John | President and CEO |
Mar 26 '25 |
Buy |
0.55 |
181,818 |
100,000 |
2,299,222 |
1.69%
0.02%
大文字化:
|
ボリューム (24 時間):